Literature DB >> 16196077

Activity and expression of the vanilloid receptor 1 (TRPV1) is altered by long-term diabetes in epineurial arterioles of the rat sciatic nerve.

Eric P Davidson1, Lawrence J Coppey, Mark A Yorek.   

Abstract

BACKGROUND: Epineurial arterioles of the sciatic nerve are innervated by sensory nerves containing calcitonin gene-related peptide (CGRP). We postulated that treating these resistance vessels with capsaicin would cause the release of endogenous CGRP and vascular relaxation.
METHODS: Videomicroscopy was used to examine the effect of capsaicin and neuropeptides on vascular reactivity of epineurial arterioles from control and streptozotocin-induced diabetic rats. Using immunohistochemistry, we examined expression of neuropeptide Y (NPY) and vanilloid receptor 1 in epineurial arterioles.
RESULTS: Instead of relaxation, capsaicin was found to cause a concentration-dependent vasoconstriction in epineurial arterioles. The effect of capsaicin was transient, refractory, blocked by capsazepine and duplicated by resiniferatoxin. When examining potential candidates for the mediation of capsaicin-induced constriction, we found that vasopressin (VP), NPY, serotonin (5HT) and endothelin (ET), but not neurokinin A or substance P, caused a concentration-dependent vasoconstriction of epineurial arterioles. Epineurial arterioles express NPY and receptor antagonists to NPY significantly decreased capsaicin-induced vasoconstriction. In long-term diabetic rats, vasoconstriction to capsaicin was significantly attenuated. However, long-term diabetes did not impair vasoconstriction of epineurial arterioles to exogenous VP, NPY, 5HT or ET. Examining the expression of vanilloid receptor 1 in epineurial arterioles from control and long-term diabetic rats, we found that immunoreactivity for vanilloid receptor 1 was decreased by diabetes.
CONCLUSIONS: These studies suggest that long-term diabetes causes vascular dysfunction in epineurial arterioles of the sciatic nerve that includes a decrease in capsaicin-induced vasoconstriction that is likely due to a decrease in the expression of vanilloid receptor 1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16196077     DOI: 10.1002/dmrr.599

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  5 in total

Review 1.  Small molecule vanilloid TRPV1 receptor antagonists approaching drug status: can they live up to the expectations?

Authors:  Arpad Szallasi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-06-14       Impact factor: 3.000

2.  Vanilloid receptor-1 (TRPV1) expression and function in the vasculature of the rat.

Authors:  Attila Tóth; Agnes Czikora; Eniko T Pásztor; Beatrix Dienes; Péter Bai; László Csernoch; Ibolya Rutkai; Viktória Csató; Ivetta S Mányiné; Róbert Pórszász; István Edes; Zoltán Papp; Judit Boczán
Journal:  J Histochem Cytochem       Date:  2013-11-11       Impact factor: 2.479

3.  Functional magnetic resonance imaging of the spinal cord during sensory stimulation in diabetic rats.

Authors:  Krisztina L Malisza; Cheryl Jones; Marco L H Gruwel; Derek Foreman; Paul Fernyhough; Nigel A Calcutt
Journal:  J Magn Reson Imaging       Date:  2009-08       Impact factor: 4.813

Review 4.  Vascular Impairment of Epineurial Arterioles of the Sciatic Nerve: Implications for Diabetic Peripheral Neuropathy.

Authors:  Mark A Yorek
Journal:  Rev Diabet Stud       Date:  2015-08-10

Review 5.  Vascular Dysfunction in Diabetes and Obesity: Focus on TRP Channels.

Authors:  Raiana Dos Anjos Moraes; R Clinton Webb; Darízy Flávia Silva
Journal:  Front Physiol       Date:  2021-02-26       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.